INVO: INVO Bioscience, Inc. Forward P/E Multiple
Optimized delivery of infertility treatment systems reduces patient costs, while operations within the US mitigate external political risks. The innovative embryo maturation method in INVOcell creates a significant competitive advantage in reproductive medicine. The trend of the company's expected P/E ratio on GURU.Markets contains critical data, where the 0.00 metric serves as the target level.
INVO Bio (INVO) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- market capitalization information:
- book capitalization information:
- debt and liquidity details:
Total Debt to Capital INVO Bioscience, Inc.|INVO - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio INVO Bioscience, Inc.|INVO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio INVO Bioscience Inc.|INVO - Company Long-Term Liabilities|Company Short-Term Debts INVO Bioscience|Quick Ratio invobioscience.com
- financial results and valuation multiples details:
INVO - Company Profit|Projected Future Earnings INVO Bioscience, Inc.|INVO - Business Payback Period|Forward P/E Multiple INVO Bioscience, Inc.|INVO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple INVO Bioscience Inc.|INVO - Operating profit EBITDA|Earnings per share for the last twelve months INVO Bioscience|INVO - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months invobioscience.com|INVO - Earnings per share increase in current year|Earnings growth forecast for next year INVO Bioscience, Inc.
Fundamental valuation:INVO INVO Bioscience
The stability of INVO Bioscience, Inc. (INVO) currently depends on the success of its transformation into Janover and the implementation of AI services within real estate lending. By assessing changes in the company's expected P/E, an investor determines the value of one dollar of future earnings, which allows for the identification of market overheating or hidden risks, separating the asset's fundamental value from short-term speculative price fluctuations.
Competitors of INVO Bioscience, Inc.
Future Price to Earnings Boston Scientific Corporation (BSX)|Future Price to Earnings EW (Edwards)|Forward P/E Multiple RMD (ResMed Corp)|Market Cap to Projected Earnings Insulet Inc. (PODD)|ZBH: Projected Price to Earnings|Price to Expected Earnings Ratio COO|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Inc (GMED)|TMDX (TransMedics Group) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec Corp)|Projected Price to Earnings AORT (Artivion, Inc.)|ENOV (enovis.com) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Holdings Corporation IART|ESTA - Projected Price to Earnings|Beta Bionics Corp - Forward P/E Multiple|Projected Price to Earnings Ratio IRADIMED Inc.|EMBC: Forward P/E Multiple|Price to Future Earnings Ratio TNDM|AXGN (Axogen) - Forward P/E Multiple|SI-BONE Inc (SIBN) - Market Cap to Projected Earnings|Forward P/E Multiple OFIX|Projected Price to Earnings Bioventus Global BVS|Forward P/E Multiple KIDS (OrthoPediatrics)|Forward P/E Multiple treace.com TMCI|SRTA - Future Price to Earnings|CARL: Future Price to Earnings|RXST (RxSight Corp) - Projected Price to Earnings|ClearPoint Neuro - Future Price to Earnings Multiple|STXS (Stereotaxis, Inc.) - Forward P/E Multiple|Projected Price to Earnings Ratio neurostar.com STIM|Future Price to Earnings Sight Sciences (SGHT)|Orchestra BioMed Inc. (OBIO) - Forward Price to Earnings Multiple|Anika Therapeutics, Inc. - Projected Price to Earnings|Forward P/E Multiple InspireMD Inc. NSPR|Jin Medical International Ltd - Forward P/E Multiple|Market Cap to Projected Earnings Vivani Medical, Inc. VANI|xtantmedical.com (XTNT) - Future Price to Earnings|Price to Expected Earnings Ratio NMTC (NeuroOne)|Future Price to Earnings Modular Medical Inc|Projected Price to Earnings Myomo Inc (MYO)|Forward P/E Multiple COCH|VVOS - Projected Price to Earnings Ratio|Future Price to Earnings enVVeno Medical Corp. NVNO|SINT: Price to Future Earnings Ratio|TNON: Projected Price to Earnings|Lifeward Ltd. - Market Cap to Future Earnings Ratio|AMIX: Forward P/E Multiple|IVF - Market Cap to Projected Earnings|Future Price to Earnings Bone Biologics Corp|Price to Future Earnings Ratio AXNX (Axonics Inc.)|Projected Price to Earnings BIOL (Biolase, Inc.)|Future Price to Earnings DYNT (dynatronics.com)|Future Price to Earnings Paragon 28 FNA
